JUSTFOG Official Response: JSTE's Liquidation is for Self-Protection after Serious Violations

Business by 2FIRSTS
Jun.05.2024
JUSTFOG Official Response: JSTE's Liquidation is for Self-Protection after Serious Violations
JSTE Electronics announces self-liquidation after contract dispute, urging creditors to beware of false claims. JFT responds.

Statement:

This announcement is from the official website of JUSTFOG. 2FIRSTS is dedicated to industry research and sharing more industry information. Readers are encouraged to evaluate the information and opinions presented in the article on their own.


 

On the evening of June 3rd, JSTE Electronics Technology (Dongguan) Co., Ltd. announced that its original main foreign client, JFT Co., Ltd., maliciously unilaterally terminated the contract and maliciously delayed payment, resulting in the target company incurring a loss of over 60 million yuan. The target company faced severe difficulties in operation and management, and ultimately decided to proceed with voluntary liquidation. (For more information, see 2FIRSTS report: JSTE Electronics Technology (Dongguan) Co., Ltd. announces voluntary liquidation)

 

On the afternoon of June 5th, JFT Co., Ltd. issued a statement on its official website for the brand "JUSTFOG" in response to the matter. Here is an overview of the main points.

 

  • JustFog Technology (JFT) has accused JSTE Company of defamation and will pursue legal action. 
  • JFT terminates its partnership with JSTE Company after discovering that key personnel, including Mr. Liu and Mr. Ge, had established related companies to inflate prices of raw materials and sell counterfeit products using the "JUSTFOG" registered trademark in violation of fair business practices. 
  • JSTE Company's dissolution is due to their actions of selling counterfeit e-cigarettes with the registered trademark to foreign customers outside of the e-cigarette trading platform after terminating their partnership with JFT, which led to criminal investigation unrelated to JFT. 
  • In order to prevent further losses for JSTE Company's creditors, we would like to inform all creditors that we have not defaulted on any payments to JSTE Company, and advise against falling for any deception tactics.

 

JUSTFOG Official Response: JSTE's Liquidation is for Self-Protection after Serious Violations
Official website screenshot | JUSTFOG Official Website

 

JUSTFOG Official Response: JSTE's Liquidation is for Self-Protection after Serious Violations

 

JUSTFOG Official Response: JSTE's Liquidation is for Self-Protection after Serious Violations

 

The original text is: 

 

A Letter to Creditors of Jiasite Technology (Dongguan) Co., Ltd.

 

Jiaste Technology (Dongguan) Co., Ltd. creditors, our company noticed an article titled "Jiaste Electronic Technology (Dongguan) Co., Ltd. self-liquidation announcement" on e-cigarette public accounts and other online platforms on June 4, 2024 Beijing time. The announcement contained defamatory statements against our company, alleging that "due to the malicious unilateral termination of contracts and malicious withholding of payments by our main foreign client, JFT Corporation, causing the company to incur losses exceeding 60 million yuan, the company has encountered severe operational difficulties." (quote from excerpt of "Jiaste Electronic Technology (Dongguan) Co., Ltd. self-liquidation announcement")

 

The false rumors spread rapidly on the internet after being reposted by some media outlets, causing a negative impact. The actions of Jiaeste Company have constituted defamation, and we will pursue legal action against them. In order to clear our name, we are writing to the creditors of Jiaeste Company as follows:

 

During our cooperation with JSTE Company, we have always upheld the principle of good faith cooperation and fulfilled the relevant provisions in both parties' contract as agreed.

 

Our company has terminated the partnership with JSTE Company due to the discovery that the actual controllers Liu X, Ge X, and other senior executives have privately established related companies to inflate raw material procurement prices and sell counterfeit products with the "JUSTFOG" registered trademark, which has gone against the principles of ethical cooperation and legality.

 

The main reason for the dissolution of JSTEE Company this time is that after we terminated cooperation with them, they resorted to selling counterfeit e-cigarettes with registered trademarks to foreign customers through circumvention of the e-cigarette trading platform, leading to their self-preservation actions in response to criminal investigations, which are unrelated to our company.

 

In order to prevent further losses for the creditors of Jest Company, we would like to inform all creditors that our company does not owe any money or other cooperation funds to Jest Company. Please do not be deceived.

 

Please publish, repost, or circulate any misleading information related to the subject promptly delete all content suspected of infringement, and stop all actions such as forwarding and commenting that may lead to the spread of such misleading information, in order to prevent further harm.

 

Thank you all for your attention and support for our company!!!

 

JFT Corporation

 

June 4, 2024

 

2FIRSTS will continue to monitor and follow up on this event, so stay tuned.

 

Click on the texts or images to read: "Beware of e-cigarette industry debt risks: How does the operational dilemma of a single enterprise affect the entire industry chain?"

 

JUSTFOG Official Response: JSTE's Liquidation is for Self-Protection after Serious Violations

 

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
Bret Koplow, acting director of the U.S. Food and Drug Administration's Center for Tobacco Products, will deliver a keynote and participate in a fireside chat at the National Association of Tobacco Outlets' Sept. 29-30 conference in Washington. His appearance comes months after the FDA moved to accelerate PMTA reviews and introduced a more differentiated enforcement policy for certain unauthorized ENDS and oral nicotine pouch products. The agency also plans a public list identifying manufacturers and products it does not currently intend to prioritize for enforcement under the May guidance. NATO says its membership includes more than 66,000 retail stores, making product-status transparency and enforcement boundaries directly relevant to the retail sector.
Aug.14
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
The FDA authorized the JUUL2 device and tobacco- and menthol-flavored pods on Aug. 28, bringing the number of authorized e-cigarette products to 48. The agency highlighted complete switching among adult smokers, with six-week switching rates reaching 28.4%–49.3% for the menthol pod. The decision comes as FDA works to speed PMTA reviews, reduce application backlogs and expand authorized e-cigarette and nicotine-pouch products while maintaining enforcement priorities for unauthorized products.
Regulations
Aug.29
Nicotine Pouches Gain Ground in U.S. Convenience Stores as Vape Unit Sales Fall 14%
Nicotine Pouches Gain Ground in U.S. Convenience Stores as Vape Unit Sales Fall 14%
According to convenience retail publication CStore Decisions, U.S. convenience store tobacco categories are undergoing a structural shift. Based on Circana OmniMarket Total U.S. Convenience data for the 52 weeks ending June 14, 2026, cigarettes remained the largest category with $50.8 billion in sales, but unit sales declined 5.3%. Electronic smoking devices and vaping products also declined, while modern oral nicotine products continued to grow, with nicotine pouch sales rising 29% in dollars and 17% in units. Retailers said changing consumer preferences are reshaping tobacco product assortments at convenience stores.
Regulations
Aug.07
Gallup Tracks Nicotine Pouch Use for the First Time: 11% of U.S. Adults Smoke, 9% Vape and 4% Use Nicotine Pouches
Gallup Tracks Nicotine Pouch Use for the First Time: 11% of U.S. Adults Smoke, 9% Vape and 4% Use Nicotine Pouches
Gallup’s 2026 Consumption Habits survey tracked nicotine pouch use for the first time. The survey found that 11% of U.S. adults reported smoking cigarettes in the past week, 9% reported vaping, and 4% reported using nicotine pouches. Cigarette smoking remained near Gallup’s long-term low, while adult vaping rates stayed relatively stable in recent years.
Market
Aug.25 by 2Firsts Perspectives
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
The FDA has authorized four additional on! nicotine pouches, bringing the U.S. total to 30. The decision marks another outcome of the agency’s nicotine pouch review pilot, whose communication and review practices are now being applied more broadly across the category. It also extends Helix’s authorized portfolio from on! PLUS to the earlier on! line. Yet all FDA-authorized nicotine pouches still come from subsidiaries of PMI or Altria, underscoring how concentrated U.S. regulatory access remains.
Aug.05
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07